Dr. Nair is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
16659 Southwest Freeway
Suite 131
Sugar Land, TX 77479Phone+1 281-276-5200Fax+1 281-276-5201
Summary
- Dr. Sindhu Nair is an oncologist in Sugar Land, TX and is affiliated with multiple hospitals in the area, including Houston Methodist Sugar Land Hospital, Houston Methodist West Hospital, and Houston Methodist Hospital. She received her medical degree from Baylor College of Medicine and has been in practice 13 years. She specializes in hematologic oncology and is experienced in thoracic cancer, gastrointestinal cancer, colorectal cancer, hematologic oncology, breast cancer, gynecologic cancers and cancer genetics. She also specializes in benign hematology.
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013- Baylor College of MedicineResidency, Internal Medicine, 2004 - 2007
- Baylor College of MedicineClass of 2004
Certifications & Licensure
TX State Medical License 2009 - 2025
PA State Medical License 2008 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer Start of enrollment: 2019 Apr 05
- A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) Start of enrollment: 2022 Aug 03
Publications & Presentations
PubMed
- 10 citationsA Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.Kai Sun, Yitian Xu, Licheng Zhang, Polly Niravath, Jorge Darcourt
Clinical Cancer Research. 2022-10-14 - 5 citationsANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancerEmre Koca, Polly A. Niravath, Joe Ensor, Tejal Patel, Xiaoxian Li
Breast Cancer Research and Treatment. 2021-04-15
Press Mentions
Beat the Pack’ Program to Help People Quit Smoking Offered at Houston Methodist Sugar Land HospitalNovember 14th, 2019
Colorectal Cancer Seminar Fighting Rare, Genetic Colorectal CancerFebruary 2nd, 2017
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
